Senior insider sale
EVP, Chief Financial Officer at TEVA PHARMACEUTICAL INDUSTRIES LTD — senior position signals high conviction
$952.5K
55.77K shares
What this filing means
KALIF ELIYAHU SHARON plans to sell 55.77K shares of TEVA PHARMACEUTICAL INDUSTRIES LTD valued at approximately $952.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/12/2025ACC: 0001973379-25-000186
Officer· EVP, Chief Financial Officer
Since Dec 2019
55.77K
Shares to sell
$952.5K
Approx. market value
55.77K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months2
SHARES FROM ROLLOVER
COMPENSATION
3/4/2024
22.26KSHARES FROM ROLLOVER
COMPENSATION
3/6/2023
33.51KTotal acquired55.77K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/4/2024 | SHARES FROM ROLLOVER COMPENSATION | 22.26K | — |
3/6/2023 | SHARES FROM ROLLOVER COMPENSATION | 33.51K | — |
| Total | 55.77K | ||
Planned & Completed Dispositions1
NYSEPlanned
Units to sell
55.77K
Market value
$952.5K
6/12/2025
Total
Units
55.77K
Value
$952.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
6/12/2025 | 55.77K | $952.5K | NYSE | Planned |
| Total | 55.77K | $952.5K | ||